ArticlemedRxiv : the preprint server for health sciences2020

Dose prediction for repurposing nitazoxanide in SARS-CoV-2 treatment or chemoprophylaxis.

Rajith Kr Rajoli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.